From amadis@io.orgThu Oct 27 12:12:46 1994
Date: 25 OCT 1994 10:44:08 -0400 
From: Amadis <amadis@io.org>
Newsgroups: misc.health.alternative
Subject: OxyTherapy Mailing List 


                       Welcome to OxyTherapies!

OxyTherapy is an InterNet Mailing List dedicated to exploring
oxygen/ozone and its related therapies as both prophylaxis
(prevention) and treatment of immune disease, and to promoting
general well-being and good health.  This is a moderated forum
with a clear bias in favour of the use of oxygen therapies;  those 
who are not open to such therapies should not subscribe to this
forum.  The OxyTherapy Mailing List is for information
sharing;  thus, it constitutes neither medical nor legal advice.
   
To subscribe to the mailing list, simply send a request to
OxyTherapy@Blade.com and in the body of your message, make sure
that you include one of the following three words: SUBSCRIBE, JOIN
or ADD.  To get a specific OxyFile, send a request to 
FTPMAIL@BLADE.COM and on the first line of your message, input GET 
FILENAME.EXT;  or to get a list of all OxyFiles available, input GET 
OXYLIST.TXT

To send messages to others subscribing to the mailing list, address
the message to OxyTherapy@Blade.Com


The goals of the OxyTherapy Mailing List are as follows.

 1.   to maintain an electronic forum which provides
      reliable/accurate information on all forms of oxygen/ozone
      therapies
 2.   to maintain an on-line library/archive of files and to make
      same available through FTP (File transfer Protocol)
 3.   to establish and maintain a database of persons, products and
      events having to do with oxygen/ozone therapies
 4.   to conduct research using the on-line forum as a study base,
      and to advocate for the establishment of a clinical trial, and
      to fundraise where needed
 5.   to establish and maintain, if a need is identified, a limited
      voice response information service

 The moderator of this forum is MrOxy.
                                                                                                              

